Entheon Biomedical

About:

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

Website: https://entheonbiomedical.com/

Twitter/X: entheonbiomed

Description:

Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products ("DMT Products") for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Coquitlam, British Columbia, Canada

Founded Date:

2010-04-06

Founders:

Timothy Ko

Number of Employees:

11-50

Last Funding Date:

2022-04-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai